Compound Detail
CHEMBL416557
DIOXIFEDRINE 🧪 Phase II
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase II
Basic Information
| ChEMBL ID | CHEMBL416557 |
| Name | DIOXIFEDRINE |
| Phase | Phase II |
| Structure Type | MOL |
| InChI Key | DDBFLXGTCAVAFD-UHFFFAOYSA-N |
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
1
Publications
3
Known Names
Molecular Properties
197.2
MW (Da)
0.74
ALogP
4
HBA
4
HBD
72.7
PSA (Ų)
0.54
QED
0
Ro5 Violations
3
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Racemic |
Activity Summary
Ki 1 meas. best 4.55
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Adrenergic receptor alpha-1 CHEMBL1907610 | Ki | 4.55 | 4.55 | 28000.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Adrenergic receptor alpha-1 | Ki | = | 28000.0 | nM | 4.55 | Compound was evaluated for inhibition of [3H]prazosin binding to Alpha-1 adrener... | 7328589 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 7328589 | 10.1021/jm00142a027 | Adrenergic receptor alpha-1 | 1 |
Data from ChEMBL 36 via Core Engine